Lisong Shen
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 2%
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
-
- Cancer-related gene regulation 10
- Advanced biosensing and bioanalysis techniques 9
- Immunology 27
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 7
- Immune cells in cancer 6
- Co-authors
- Guohua Xie (25 shared papers)Xiangliang Yuan (18 shared papers)Yanhui Ma (18 shared papers)Qin Luo (6 shared papers)Ke Xing (7 shared papers)Peiming Zheng (5 shared papers)Lei Chen (2 shared papers)Yingxia Zheng (20 shared papers)
- Journals
- PLoS ONE (4 papers)European Journal of Immunology (3 papers)Frontiers in Immunology (3 papers)Annals of Clinical Microbiology and Antimicrobials (3 papers)Clinical & Experimental Immunology (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lisong Shen
93 papers receiving 3.7k citations
Lisong Shen's Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 751
- Immunology 876
- Molecular Biology 1.7k
- Oncology 637
- Molecular Medicine 98
Countries citing papers authored by Lisong Shen
This map shows the geographic impact of Lisong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisong Shen more than expected).
Fields of papers citing papers by Lisong Shen
This network shows the impact of papers produced by Lisong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisong Shen. The network helps show where Lisong Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisong Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells Hit paper breakdown → | 2017 | 510 |
| 2 | 2018 | 310 | |
| 3 | 2020 | 300 | |
| 4 | 2011 | 246 | |
| 5 | 2017 | 167 | |
| 6 | 2019 | 124 | |
| 7 | 2021 | 101 | |
| 8 | 2020 | 93 | |
| 9 | 2012 | 87 | |
| 10 | 2004 | 83 | |
| 11 | 2021 | 65 | |
| 12 | 2012 | 65 | |
| 13 | 2004 | 60 | |
| 14 | 2013 | 52 | |
| 15 | 2016 | 47 | |
| 16 | 2016 | 47 | |
| 17 | 2018 | 46 | |
| 18 | 2020 | 45 | |
| 19 | 2017 | 44 | |
| 20 | 2017 | 43 |
About Lisong Shen
Lisong Shen is a scholar working on Molecular Biology, Immunology, Oncology, Biomedical Engineering and Cancer Research, having authored 94 papers that have together received 3.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (14 papers), Biosensors and Analytical Detection (10 papers), Cancer-related gene regulation (10 papers), Advanced biosensing and bioanalysis techniques (9 papers), T-cell and B-cell Immunology (7 papers), Immune cells in cancer (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). The work is most often cited by research in Cancer Research (751 citations), Immunology (876 citations), Molecular Biology (1.7k citations), Oncology (637 citations) and Molecular Medicine (98 citations). Lisong Shen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Guohua Xie, Xiangliang Yuan, Yanhui Ma, Qin Luo, Ke Xing, Peiming Zheng, Lei Chen, Yingxia Zheng, Yi Liu and Junyao Yang. Their work appears in journals such as PLoS ONE, European Journal of Immunology, Frontiers in Immunology, Annals of Clinical Microbiology and Antimicrobials and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.